2023-506035-15-00已完成4 期
RANDOMISED, CROSSOVER BIOEQUIVALENCE CLINICAL TRIAL OF APIXABAN 5 MG CAPSULES VS APIXABAN 5 MG FILM-COATED TABLETS, AFTER A SINGLE ORAL DOSE ADMINISTRATION TO HEALTHY VOLUNTEERS UNDER FASTING CONDITIONS.
Laboratorios Alter S.A.1 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2023年8月11日最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 36
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Carmen Morillo Alonso
Scientific
Laboratorios Alter S.A.
研究点 (1)
Loading locations...
相似试验
招募中
4 期
Randomised, crossover bioequivalence clinical trial of edoxaban 60 mg film-coated tablets, after a single oral dose administration to healthy volunteers under fasting conditions.2022-502085-24-00Biohorm S.L.15
已完成
4 期
Randomised, crossover bioequivalence clinical trial of linagliptin/metformin 2.5 mg/1000 mg film-coated tablets, after a single oral dose administration to healthy volunteers under fed conditions.diabetes2024-512310-18-00Laboratorios Alter S.A.36
进行中（未招募）
1 期
A RANDOMIZED BIOEQUIVALENCE STUDY OF EFAVIRENZ GENERIC DRUG AND SUSTIVA® (TABLETS 600 mg) IN PATIENTS WITH HIV-1Patients with HIV-1MedDRA version: 20.0Level: LLTClassification code 10020192Term: HIV-1System Organ Class: 100000004862EUCTR2015-003278-34-ITIRCCS- ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI40
已完成
1 期
Pivotal in vivo bioequivalence study comparing two formulations of 21-acetoxyl group-11 beta-hydroxy-6 Alpha-Methyls-17-propiono Oxy-1,4-pregnen diethylene-3,20-diketone fatty ointment applied to the skin in healthy male and female volunteers.21-acetoxyl group-11 beta-hydroxy-6 Alpha-Methyls-17-propiono Oxy-1,4-pregnen diethylene-3,20-diketone fatty ointment is indicated for the short term treatment of the milder form of eczema, dermatitis and other steroid responsive skin conditionsSkin - Dermatological conditionsACTRN12623000571673Zenith Technology Corporation Limited90
已完成
1 期
Pivotal in vivo bioequivalence study comparing two formulations of 21-acetoxyl group-11 beta-hydroxy-6 Alpha-Methyls-17-propiono Oxy-1,4-pregnen diethylene-3,20-diketone ointment applied to the skin in healthy male and female volunteers.21-acetoxyl group-11 beta-hydroxy-6 Alpha-Methyls-17-propiono Oxy-1,4-pregnen diethylene-3,20-diketone ointment is indicated for the short term (up to 7 days) treatment of the milder form of eczema, dermatitis and other steroid responsive skin conditions which do not require the use of a more active topical corticosteroidSkin - Dermatological conditionsACTRN12622001421729Zenith Technology Corporation Limited90